These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22023061)

  • 1. Botulinum toxin injections into the detrusor.
    Wöllner J; Kessler TM
    BJU Int; 2011 Nov; 108(9):1528-37. PubMed ID: 22023061
    [No Abstract]   [Full Text] [Related]  

  • 2. Intradetrusor injection of botulinum toxin for the management of refractory overactive bladder syndrome: an update.
    Al-Shaiji TF
    Surg Innov; 2013 Aug; 20(4):351-5. PubMed ID: 22964263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of botulinum toxin in the treatment of refractory overactive bladder.
    Mucksavage P; Smith AL; Moy ML
    Ostomy Wound Manage; 2006 Dec; 52(12):28, 30, 32-3. PubMed ID: 17219700
    [No Abstract]   [Full Text] [Related]  

  • 4. Injectable neuromodulatory agents: botulinum toxin therapy.
    Frenkl TL; Rackley RR
    Urol Clin North Am; 2005 Feb; 32(1):89-99. PubMed ID: 15698881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated botulinum toxin injections: a new answer for further questions.
    Lazzeri M
    Eur Urol; 2007 Dec; 52(6):1571-3. PubMed ID: 17854985
    [No Abstract]   [Full Text] [Related]  

  • 6. The case for bladder botulinum toxin application.
    Kim DK; Thomas CA; Smith C; Chancellor MB
    Urol Clin North Am; 2006 Nov; 33(4):503-10, ix. PubMed ID: 17011386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Botulinum toxin in the treatment of achalasia].
    Ponce García J
    Gastroenterol Hepatol; 1998; 21(6):289-93. PubMed ID: 9711013
    [No Abstract]   [Full Text] [Related]  

  • 8. [How I do… the intra-detrusor injection of botulinum toxin for overactive bladder management].
    Cerruto E; Lamblin G; Vernier L; Lebail-Carval K; Chabert P; Mellier G; Chene G
    Gynecol Obstet Fertil Senol; 2019 Jan; 47(1):79-81. PubMed ID: 30502106
    [No Abstract]   [Full Text] [Related]  

  • 9. Botulinum toxin: new option for refractory lower urinary tract symptoms in women.
    Rickey LM; Kenton K
    Clin Obstet Gynecol; 2008 Mar; 51(1):176-86. PubMed ID: 18303512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin for the treatment of lower urinary tract symptoms: a review.
    Sahai A; Khan M; Fowler CJ; Dasgupta P
    Neurourol Urodyn; 2005; 24(1):2-12. PubMed ID: 15578628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with injections of botulinum toxin type A into the detrusor muscle.
    Miyagawa I; Watanabe T; Isoyama T; Honda M; Kobayasi N; Hikita K; Saito M; Hirakawa S
    Aktuelle Urol; 2010 Jan; 41 Suppl 1():S24-6. PubMed ID: 20094947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin therapy for neurogenic detrusor overactivity.
    Smaldone MC; Ristau BT; Leng WW
    Urol Clin North Am; 2010 Nov; 37(4):567-80. PubMed ID: 20955908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of facial spasm using botulinum toxin].
    Asanuma K; Kaji R
    No Shinkei Geka; 2003 May; 31(5):487-91. PubMed ID: 12755021
    [No Abstract]   [Full Text] [Related]  

  • 14. Botulinum toxin as a treatment for tardive dyskinesia.
    van Harten PN; Hovestadt A
    Mov Disord; 2006 Aug; 21(8):1276-7. PubMed ID: 16671083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periodic alternating nystagmus treated with retrobulbar botulinum toxin and large horizontal muscle recession.
    Thomas R; Mathai A; Braganza A; Billson F
    Indian J Ophthalmol; 1996 Sep; 44(3):170-2. PubMed ID: 9018998
    [No Abstract]   [Full Text] [Related]  

  • 16. In-office transnasal esophagoscope-guided botulinum toxin injection of the lower esophageal sphincter.
    Rees CJ
    Curr Opin Otolaryngol Head Neck Surg; 2007 Dec; 15(6):409-11. PubMed ID: 17986880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse events of intravesical botulinum toxin a injections for idiopathic detrusor overactivity: risk factors and influence on treatment outcome.
    Kuo HC; Liao CH; Chung SD
    Eur Urol; 2010 Dec; 58(6):919-26. PubMed ID: 20864251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of urodynamic and detrusor contractility variables in patients with overactive bladder syndrome treated with botulinum toxin-A: is incomplete bladder emptying predictable?
    Sahai A; Sangster P; Kalsi V; Khan MS; Fowler CJ; Dasgupta P
    BJU Int; 2009 Mar; 103(5):630-4. PubMed ID: 18990156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin-A injections into neurogenic overactive bladder--to include or exclude the trigone? A prospective, randomized, controlled trial.
    Abdel-Meguid TA
    J Urol; 2010 Dec; 184(6):2423-8. PubMed ID: 20952003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher or lower doses of botulinum toxin for the treatment of chronic anal fissure?
    Madalinski MH
    Gastroenterology; 2003 Apr; 124(4):1165. PubMed ID: 12671920
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.